5 results for author:"Iliceto S." in Literature citations
Results Customize
| Circulating beta2 glycoprotein I-IgG anti-beta2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome. Banzato A., Frasson R., Acquasaliente L., Bison E., Bracco A., Denas G., Cuffaro S., Hoxha A., Ruffatti A., Iliceto S. et al. Lupus 21:784-786(2012) · Mapped (3) |
| Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages. Osto E., Kouroedov A., Mocharla P., Akhmedov A., Besler C., Rohrer L., von Eckardstein A., Iliceto S., Volpe M., Luscher T.F. et al. Circulation 118:2174-2182(2008) · Mapped (1) |
| c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Osto E., Matter C.M., Kouroedov A., Malinski T., Bachschmid M., Camici G.G., Kilic U., Stallmach T., Boren J., Iliceto S. et al. Circulation 118:2073-2080(2008) · Mapped (4) |
| Antibodies to oxidized LDL/beta2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Pengo V., Bison E., Ruffatti A., Iliceto S. Thromb. Res. 122:556-559(2008) · Mapped (3) |
| Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation. Pengo V., Filippi B., Biasiolo A., Pegoraro C., Noventa F., Iliceto S. Am. J. Cardiol. 90:545-547(2002) · Mapped (21) |